199 related articles for article (PubMed ID: 21911798)
21. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
[TBL] [Abstract][Full Text] [Related]
22. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.
Mauritz C; Martens A; Rojas SV; Schnick T; Rathert C; Schecker N; Menke S; Glage S; Zweigerdt R; Haverich A; Martin U; Kutschka I
Eur Heart J; 2011 Nov; 32(21):2634-41. PubMed ID: 21596799
[TBL] [Abstract][Full Text] [Related]
23. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.
Banquet S; Gomez E; Nicol L; Edwards-Lévy F; Henry JP; Cao R; Schapman D; Dautreaux B; Lallemand F; Bauer F; Cao Y; Thuillez C; Mulder P; Richard V; Brakenhielm E
Circulation; 2011 Aug; 124(9):1059-69. PubMed ID: 21824923
[TBL] [Abstract][Full Text] [Related]
24. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
25. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
Chen HK; Hung HF; Shyu KG; Wang BW; Sheu JR; Liang YJ; Chang CC; Kuan P
Eur J Clin Invest; 2005 Nov; 35(11):677-86. PubMed ID: 16269017
[TBL] [Abstract][Full Text] [Related]
26. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
[TBL] [Abstract][Full Text] [Related]
27. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.
Bonaros N; Rauf R; Wolf D; Margreiter E; Tzankov A; Schlechta B; Kocher A; Ott H; Schachner T; Hering S; Bonatti J; Laufer G
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1321-8. PubMed ID: 17140950
[TBL] [Abstract][Full Text] [Related]
28. Increment and impairment of adiponectin in renal failure.
Komura N; Kihara S; Sonoda M; Maeda N; Tochino Y; Funahashi T; Shimomura I
Cardiovasc Res; 2010 Jun; 86(3):471-7. PubMed ID: 20035033
[TBL] [Abstract][Full Text] [Related]
29. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
30. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
31. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
33. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
[TBL] [Abstract][Full Text] [Related]
34. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
Abbate A; Salloum FN; Vecile E; Das A; Hoke NN; Straino S; Biondi-Zoccai GG; Houser JE; Qureshi IZ; Ownby ED; Gustini E; Biasucci LM; Severino A; Capogrossi MC; Vetrovec GW; Crea F; Baldi A; Kukreja RC; Dobrina A
Circulation; 2008 May; 117(20):2670-83. PubMed ID: 18474815
[TBL] [Abstract][Full Text] [Related]
35. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
36. Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction.
Pelzer T; Loza PA; Hu K; Bayer B; Dienesch C; Calvillo L; Couse JF; Korach KS; Neyses L; Ertl G
Circulation; 2005 Mar; 111(12):1492-8. PubMed ID: 15781739
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
38. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
[TBL] [Abstract][Full Text] [Related]
39. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.
Tao L; Wang Y; Gao E; Zhang H; Yuan Y; Lau WB; Chan L; Koch WJ; Ma XL
Circ Res; 2010 Feb; 106(2):409-17. PubMed ID: 19940263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
